APA Corporation Form 8-K Summary
Business context and reporting period
APA filed this Item 8.01 Current Report on March 15, 2024. The filing supplements APA’s definitive joint proxy statement/prospectus regarding its proposed acquisition of Callon Petroleum Company. It is not a quarterly or annual financial-results filing and does not provide current-period revenue, earnings, cash flow, margin, liquidity, or debt results.
- APA stockholders and Callon stockholders were scheduled to vote on the transaction on March 27, 2024.
- The transaction would merge Callon into an APA subsidiary, with Callon surviving as a wholly owned APA subsidiary.
- Each Callon share would be exchanged for 1.0425 APA shares, with cash paid in lieu of fractional shares.
Key financial and transaction metrics
| Item | Disclosure |
|---|---|
| Expected annual synergies | Approximately $150 million at ultimate annual run rate: $55 million from public-company and general and administrative cost reductions, $40 million from financing-cost savings, and $55 million from operating efficiencies. |
| Callon financial adviser fee | RBC Capital Markets agreed to an aggregate $13.0 million fee; $2.5 million was paid upon signing and the balance is contingent on closing. |
| Historical adviser fees | During approximately the two years before December 29, 2023, RBC Capital Markets and affiliates received approximately $6.37 million from Callon and $2.6 million from APA for services. |
| APA net debt used in Morgan Stanley analysis | $5.098 billion as of the analysis date, with $441 million of equity investments added and $317 million of cash-settled awards deducted. |
| Callon net debt used in Morgan Stanley analysis | $1.932 billion, with $41 million of asset retirement obligations, $362 million of net working capital, and $2 million of cash-settled awards also deducted. |
| Fully diluted shares used in analysis | Approximately 304.1 million APA shares and 67.3 million Callon shares. |
The filing does not provide APA’s current revenue, net income, operating cash flow, free cash flow, operating margins, cash balance, or debt balances beyond amounts used in transaction valuation analyses.
Material changes versus prior disclosure
- APA and Callon disclosed additional information in response to stockholder demand letters and litigation alleging deficiencies or omissions in the proxy statement/prospectus.
- The supplemental disclosures state that APA did not discuss management retention or equity participation with Callon management, other than treatment of existing equity awards.
- The filing provides additional details regarding RBC Capital Markets’ compensation, prior services, and lending relationships with both companies.
- Additional transaction-process disclosures describe APA’s December 26 proposal for a 1.020 exchange ratio, approximately $50 million of immediately available annual overhead synergies, bridge financing commitments, and proposed termination fees of $95 million for Callon and $115 million for APA. The signed transaction subsequently reflected a 1.0425 exchange ratio.
- Callon’s board ratified and affirmed its prior merger approvals by unanimous written consent on March 15, 2024. No potential counterparties had contacted Callon or its advisers regarding an acquisition since the transaction announcement through that date.
- Updated valuation analyses include APA standalone implied per-share ranges of $33.25 to $40.70 under discounted cash flow analysis and $36.40 to $39.10 under net asset value analysis. Callon ranges were $31.00 to $40.70 without synergies and $35.40 to $45.60 including synergies under discounted cash flow analysis.
Guidance, outlook, risks, contingencies, and unusual items
- Management and advisers expect the merger to provide near-term operational, overhead, and financing efficiencies, but the $150 million synergy estimate is forward-looking and may not be achieved.
- Two APA stockholder demand letters, thirteen Callon stockholder demand letters, and five complaints had been received or filed as of March 15, 2024. The complaints allege disclosure deficiencies. APA believes the claims lack merit but cannot predict the outcome or estimate any potential loss.
- Additional complaints, demand letters, or amended complaints may be filed, and APA does not intend to announce each similar filing.
- Completion remains subject to stockholder approval and other closing conditions. Risks include failure to close, termination rights, regulatory or tax issues, integration difficulties, unexpected liabilities or costs, employee-retention challenges, financing and credit-market access, and failure to realize projected synergies.
- The transaction may expose the combined company to additional commodity, geopolitical, operational, integration, and execution risks associated with APA’s diversified global asset portfolio.
- The filing contains customary forward-looking statements and does not constitute an offer to buy or sell securities or a solicitation of votes outside applicable securities-law requirements.
Important facts for investors to verify
- Confirm the March 27, 2024 stockholder vote results and whether all other merger conditions were satisfied.
- Verify the final exchange ratio, transaction closing date, share issuance, and any termination or transaction-related fees.
- Assess whether the stated $150 million annual synergy target is achieved, including timing, one-time implementation costs, and financing savings.
- Review the status and potential financial impact of the stockholder litigation and demand letters.
- Reconcile transaction valuation assumptions, including commodity-price forecasts, discount rates, EBITDA multiples, net debt, reserves, and projected free cash flow.
- Review the definitive proxy statement/prospectus, APA’s 2023 Form 10-K, and subsequent filings for updated debt, liquidity, operating results, and risk disclosures.